Abstract

Oncology patients frequently use herbal and other forms of complementary medicine, often without the knowledge of oncologists, pharmacists, and other healthcare professionals responsible for their care. Oncology healthcare professionals may lack the knowledge needed to guide their patients on the safe and effective use of herbal medicinal products, a number of which have potentially harmful effects, which include direct toxicity and negative herb–drug interactions. The current review addresses the prevalence and expectations of oncology patients from herbal medicine, as well as evidence for the beneficial or harmful effects of this practice (potential and actual), especially when the herbal products are used in conjunction with anticancer agents. Models of integrative oncology care are described, in which open and effective communication among oncologists, pharmacists, and integrative physicians on the use of herbal medicine by their patients occurs. This collaboration provides patients with a nonjudgmental and multidisciplinary approach to integrative medicine, echoing their own health-belief models of care during conventional cancer treatments. The role of the integrative physician is to facilitate this process, working with oncologists and pharmacists in the fostering of patient-centered palliative care, while ensuring a safe and effective treatment environment. Case scenario: W. is a 56 year old female artist who was recently diagnosed with localized hormone receptor-positive breast cancer. Following lumpectomy and sentinel node dissection, she is scheduled to begin adjuvant chemotherapy with a regimen which will include adriamycin, cyclophosphamide, and paclitaxel (AC-T protocol). She is worried about developing peripheral neuropathy and its impact on her ability to paint, and she asks about a number of dietary supplements which she heard could prevent this from happening: omega-3, vitamin E, alpha-lipoic acid, and acetyl-l-carnithine. She is concerned, however, that the supplements may negatively interact with her chemotherapy regimen.

Highlights

  • Patients with cancer often seek out nonconventional treatments for the relief of symptoms, as well as for disease-related outcomes, which include increasing survival, preventing disease recurrence, and “strengthening” their immune system [1,2,3]

  • There are a number of reasons for this lack of disclosure, including the assumption that herbal medicine use is not relevant to their oncology treatment or that their oncology health care professional (HCP) lack any knowledge on this practice and, cannot provide any guidance on their use [7]

  • The current review examines models of oncology care, in which oncologists and pharmacists can better address the use of herbal medicine by their patients

Read more

Summary

Introduction

Patients with cancer often seek out nonconventional treatments for the relief of symptoms, as well as for disease-related outcomes, which include increasing survival, preventing disease recurrence, and “strengthening” their immune system [1,2,3]. It has been shown that many oncology HCPs are unaware of the potentially harmful outcomes associated with the use of herbal medicine during active cancer care, making it difficult for them to help their patients make an informed decision on the benefits and risks of this practice [10]. The current review examines models of oncology care, in which oncologists and pharmacists can better address the use of herbal medicine by their patients. These models are invariably facilitated by integrative physicians who, working together with the patient’s oncology HCPs, provide guidance on the safe and effective use of herbal and other forms of complementary and integrative medicine within the supportive cancer care setting.

Anticancer Effects of Herbal Medicine
Herbal Medicine for Symptom Relief
Legislation and Quality Control
Direct Toxic Effects of Medicinal Herbal Products
Herb–Drug Interactions
Altered Pharmacodynamics
The Role of the Oncologist
The Role of the Pharmacist
The Role of the Integrative Physician
Pharmacist–Oncologist–Integrative Physician Communication
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call